Saturday, November 2, 2024
Home Tags Contributor Profile

Contributor Profile Related News

Therapies for recombination-deficient severe combined immunodeficiency

Therapies for recombination-deficient severe combined immunodeficiency

Leiden University Medical Center, Netherlands, is developing stem cell-based gene therapy for recombination-deficient severe combined immunodeficiency. Leiden University Medical Center is the co-ordinating partner for...
Becoming reality – mucopolysaccharide storage diseases and adulthood

Becoming reality – mucopolysaccharide storage diseases and adulthood

Susanne Gerit Kircher, of the Medical University of Vienna, explains why more resources and effort must be put into understanding mucopolysaccharide storage diseases in...
Fill That Gap makes healthcare possible whenever, wherever

Fill That Gap makes healthcare possible whenever, wherever

Fill That Gap is a small organisation with a big vision: to ensure qualified and experienced healthcare professionals are accessible to all. Several years ago,...
Trophoblast organoids for modelling of placental disorders

Trophoblast organoids for modelling of placental disorders

Researchers grew a three-dimensional organoid model of the human placenta – an achievement carrying significant implications for placental disorders. Defective placentation is the underlying cause...
Digital mobility monitoring: evidence-based pressure ulcer prevention

Digital mobility monitoring: evidence-based pressure ulcer prevention

Bertrand Hughes, CEO of compliant concept AG, outlines the cost-effectiveness of pressure ulcer prevention & the added value of digital mobility monitoring. A recent report...
Continuous low mobility, yet do not disturb!

Continuous low mobility, yet do not disturb!

Compliant concept AG’s Bertrand Hughes outlines the advantages of the Active Mobilisation System® – purposely designed for those with low mobility. Up until now, the...
EU-OPENSCREEN: research infrastructure and medicinal chemistry

EU-OPENSCREEN: research infrastructure and medicinal chemistry

Dr Wolfgang Fecke introduces EU-OPENSCREEN, a European Research Infrastructure Consortium for medicinal chemistry, supporting research and its translation to medicine and agriculture. The systematic screening...
The Ingenium Foundation: major player in the field of dementia in Bavaria

The Ingenium Foundation: major player in the field of dementia in Bavaria

The Ingenium® Foundation focuses on different issues of dementia like dementia in acute hospitals, young onset dementia, digitisation, prevention and dementia in Bavaria. The Ingenium...
Michael Lisanti and antibiotics: the next cancer revolution

Michael Lisanti and antibiotics: the next cancer revolution

Speaking to Health Europa, Professor Michael Lisanti, MD-PhD, FRSA discusses the potential role of antibiotics in preventing the recurrence of cancer. How would you cure...
Bar-Ilan University: Nano-Institute at the cutting edge of medical research

Bar-Ilan University: Nano-Institute at the cutting edge of medical research

Offering a glimpse into breakthrough research, Health Europa explores with Bar-Ilan University, their Nanotechnology Institute that’s advancing medicine. The Institute for Nanotechnology and Advanced Materials...
BioBlocks, Inc. are changing the game of drug discovery

BioBlocks, Inc.: Transforming the process of lead discovery

BioBlocks CEO Dr Peter Pallai discusses how BioBlocks is making drug discovery more straightforward, faster and more economical using data-driven approaches. BioBlocks is a medicinal...
Measuring the length of a physician’s arms – or ensuring the competencies of healthcare staff

Measuring the length of a physician’s arms – or ensuring the competencies of healthcare...

INNO-X Healthcare discuss their efforts to ensure the healthcare staff of the future are equipped with the skills and competencies they need to best...
Mucopolysaccharide storage diseases and puberty and adolescence

Mucopolysaccharide storage diseases and puberty and adolescence

The Medical University of Vienna’s Susanne Gerit Kircher reflects on the medical progress that has allowed people affected by mucopolysaccharide storage diseases to start...
Prudenta: an electronic solution for local literature monitoring in pharmacovigilance

Prudenta: an electronic solution for local literature monitoring in pharmacovigilance

Dr Polina Dombure, the managing director of Inpharmatis, introduces Prudenta, an innovative pharmacovigilance solution set to transform local literature monitoring. The costly, time-consuming and error-prone...
Neurosteer: introducing a novel brain activity monitor

Neurosteer: introducing a novel brain activity monitor

Neurosteer has developed a three-electrode neurological monitor that provides multiple brain activity biomarkers. Neurosteer has the mission to improve the quality of brain disorder care...
Sleep and pain relief on demand, from Sana Health

Sleep and pain relief on demand, from Sana Health

Sana Health introduces its neuromodulation device, which is easing pain, improving sleep, and could save many lives. IN 1992, the founder of Sana Health, Richard...
HepatoPredict: stratifying liver cancer patients for transplantation

HepatoPredict: stratifying liver cancer patients for transplantation

The HepatoPredict - a powerful predictive tool to accurately select hepatocellular carcinoma patients for successful liver transplantation. Dr José Pereira Leal, the founder and executive...
Learning from Nature understanding sustainable antibiotic use

Learning from Nature: understanding sustainable antibiotic use

There is a pressing need to better understand sustainable antibiotic use and the evolution of resistance in infectious diseases. The evolution of antibiotic-resistant pathogens poses...
New targeted methotrexate underway for rheumatoid arthritis

New targeted methotrexate underway for rheumatoid arthritis

ROS Therapeutics APS has developed a targeted methotrexate prodrug to mitigate the side effects experienced by many rheumatoid arthritis patients. Danish start-up company ROS Therapeutics...
BioMedical Design Novo Nordisk Foundation Fellowship Programme

BioMedical Design Novo Nordisk Foundation Fellowship Programme

Sys Zoffman Glud explains how the BioMedical Design Novo Nordisk Foundation Fellowship Programme will spot new potential for transforming healthcare. The healthcare sector’s unexploited potential...

Pin It on Pinterest